Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Maternal & Fetal Health

Our Maternal & Fetal Health research covers the following research groups: Lactation, Intelligent Imaging in Fetal Health, The Oxford Safer Pregnancy Alliance (OSPREA), Oxford Centre for Labour Monitoring, Placental Imaging, the INGR1D Study and Pre-eclampsia.

Our Maternal & Fetal Health research covers the following research groups: Fetal Monitoring; Lactation and Breastfeeding, The Oxford Safer Pregnancy Alliance (OSPREA), the INGR1D Study and Pre-eclampsia. © Copyright: Shutterstock


Topics in this theme

INGR1D is a large screening study in the Thames Valley to identify infants who are at risk of developing type 1 diabetes.
INGR1D Study in the Thames Valley
Intelligent Imaging in Fetal Health
Intelligent Imaging in Fetal Health
Lactation
Lactation
OSPREA & Gynae Team
OSPREA & Gynae Team
Oxford Centre for Labour Monitoring
Oxford Centre for Labour Monitoring
The placenta is the most indispensable, disposable organ you ever had. It decrees both how well we grow and develop in the womb and our future health well into adulthood. Our research explores two key themes: 1) Imaging the placenta early in pregnancy in order to predict adverse pregnancy outcomes including fetal growth restriction and 2) Diagnosis and management of Placenta Accreta Spectrum Disorder (PAS) - also known as abnormally invasive placenta (AIP).
Placental Imaging
Pre-eclampsia affects 5% of pregnant women, usually during the second half of pregnancy (from around 20 weeks) or soon after their baby is delivered. It is associated with significant problems in the mother and the baby. Our research examines the molecular mechanisms of pre-eclampsia and explores if we can predict and prevent this disease.
Pre-eclampsia